Leadership
Chris Reist, MD, MBA
Chief Medical & Science Officer
Psychiatrist and digital-health CMO with 30+ years scaling mental health care. CMO at Prairie Health, a VC-backed collaborative care platform acquired by Carbon Health. CMO for Population Health at Relias, leading development of claims-based quality measures and predictive analytics in behavioral health. Former Chief of Mental Health, Long Beach VA; Professor at UC Irvine; Medical Director at Science 37 (decentralized clinical trials). Leads clinical strategy, safety, and real-world evidence generation at Clearlight.
Todd Adamson, PsyD
Chief Experience & Therapy Officer
Board-certified clinical psychologist with 20 years of clinical and operational experience. Built and scaled the psychiatry and behavioral sciences unit at Science 37, a VC-backed decentralized clinical trials company. Diplomate in cognitive therapy, specializing in PTSD and complex trauma. Expert in technology-enhanced, virtual reality exposure therapy. Proven track record of programmatic build-out and clinical protocol deployment across multiple sites. Oversees the Clearlight patient and member experience across the full spectrum of care.
Nicolas Sohl, MBA
Chief Executive Officer
Three-time company cofounder and operator with 15 years of experience founding, financing, and scaling businesses in the health and real estate sectors. Previously Cofounder and CEO of Cell Care Therapeutics, a biotech focused on developing a first-in-class, stem cell-derived, exosome therapy for neuro-inflammatory diseases. Graduate of Duke University — The Fuqua School of Business.
David Sack, MD
Chief Strategy & Network Officer
Behavioral health entrepreneur building multi-site networks. At Aspen Education Group, he built the largest privately-owned network of publicly-funded treatment centers in California (acquired by CRC). Founded Elements Behavioral Health with Frazier Healthcare Partners, growing it to $160M revenue, 1,200 employees, across seven states. Board member of PE-backed behavioral health networks (Embark, Second Chance). Triple board-certified in adult, addiction, and geriatric psychiatry.
Barbara Rothbaum, PhD
Advisory Board: Education & Training
Pioneer of prolonged exposure (PE) therapy; Professor at Emory University School of Medicine and Executive Director of Emory Healthcare Veterans Program. Leads MAPS-funded trials combining MDMA with PE for PTSD. Former President of the International Society for Traumatic Stress Studies, the field's preeminent trauma research body; recipient of its Lifetime Achievement Award. Guides Clearlight's therapist training curriculum and education standards for psychedelic-assisted therapy.